BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 26, 2016
View Archived Issues
Chugai Pharmaceutical updates progress of second quarter 2016
Read More
Targeting Tat expression pathways may be useful for reactivation of latent HIV-1
Read More
Fetuin-B as plasma biomarker related to the severity of lung function in COPD
Read More
FDA's clinical hold on CGF-166 lifted
Read More
Topline 24-week data from phase IIb study of ALD-403 for persistent migraine prevention
Read More
FDA issues complete response letter for Ocular Therapeutix's Dextenza
Read More
Celsion reports further data from OVATION study in ovarian cancer
Read More
HHS patents TDP2 inhibitors
Read More
Valneva completes phase II study of C. difficile vaccine
Read More
Calibr discloses dimeric derivatives of amiloride
Read More
Warp Drive Bio describes CEP250 modulators
Read More
Tobira's cenicriviroc improves liver fibrosis in phase IIb study in NASH
Read More
Advinus Therapeutics presents retinoid RORgammaT antagonists
Read More
FDA grants new breakthrough therapy designation to Darzalex in multiple myeloma
Read More
Opthea reports data from ongoing first-in-human trial of OPT-302 for wet AMD
Read More
ROCK2 signaling induces a subset of TFH cells through opposing effects on STATs
Read More
Novel bispecific immunoadhesin shows promise for HIV prevention and immunotherapy
Read More
Exosome-mediated macrophage reprogramming as promising strategy for pancreatic cancer therapy
Read More
AbbVie and BMS to evaluate Rova-T with checkpoint inhibitors for SCLC
Read More
Newron plans Xadago NDA resubmission
Read More
FDA approves AbbVie's Viekira XR
Read More
FDA accepts Calithera Biosciences' IND for CB-1158
Read More
Ebola Zaire vaccine wins FDA breakthrough therapy designation and PRIME status
Read More
